Serum amylase and risk of the metabolic syndrome in Korean adults
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1
- 저널
- CLINICA CHIMICA ACTA412(19-20) · pp.1848 · 2011
- 피인용
- Web of Science 35
- JCR IF
- JCR 2010 2.389
- ISSN
- 0009-8981
저자
- 이정규제1저자Department of Family Medicine, Pusan National University School of Medicine, South Korea
- Park, Sang WookDepartment of Family Medicine, Pusan National University School of Medicine, South Korea
- 조병만Department of Preventive Medicine, Pusan National University School of Medicine, South Korea
- 이상엽교신저자Medical Education Unit and Medical Research Institute, Pusan National University School of Medicine, South Korea
- 김윤진Department of Preventive Medicine, Pusan National University School of Medicine, South Korea
- 정동욱Department of Family Medicine, Pusan National University School of Medicine, South Korea
- 이유현Department of Family Medicine, Pusan National University School of Medicine, South Korea
- 조영혜Department of Family Medicine, Pusan National University School of Medicine, South Korea
초록
Background: Serum amylase has recently been shown to be associated with ghrelin and adiponectin as well as obesity. We investigated the relationship between total amylase and metabolic syndrome in adults. Methods: 4495 adults were enrolled. All subjects denied any medical history or status of a disorder that could influence their serum amylase. Anthropometry, metabolic risk factors and total amylase concentration were measured. Each participant was categorized into one of 4 subgroups according to their total amylase concentration. Multiple logistic regression analysis was used to assess the independent association between amylase concentration and metabolic syndrome. Receiver-operating characteristics (ROC) curves analyses were used for comparison of the diagnostic value of amylase and other biomarkers for metabolic syndrome. Results: The prevalence of metabolic syndrome by the National Cholesterol Education Program criteria was 13.4%, 15.3%, 19.3%, and 24.2% of those in the fourth, third, second, and lowest quartile of amylase concentration (P for trend <0.001). After adjusting for age, sex, and body mass index, the odds ratios of the lower quartiles were significantly higher compared to the fourth quartile for the presence of metabolic syndrome. In ROC curve analysis, amylase was similar to uric acid as a significant diagnostic indicator for metabolic syndrome, but it had lower diagnostic value than alanine aminotransferase, gamma-glutamyltransferase or C-reactive protein. Conclusions: Lower amylase concentration is associated with an increased prevalence of metabolic syndrome. Amylase may contribute to identifying metabolic syndrome, although further research is needed to understand the mechanism behind these associations. (C) 2011 Elsevier B.V. All rights reserved.
키워드
Metabolic syndromeAmylasePancreasType 2 diabetesCardiovascular diseaseINTERNATIONAL DIABETES FEDERATIONINSULIN-RESISTANCE SYNDROMECIRCULATING GHRELIN LEVELSLOW PLASMA GHRELINASSOCIATIONDISEASEBLOODADIPONECTINDEFINITIONSTATEMENT
식별자
- WoS UID
- 000294396500024



로그인
연구물 목록으로